Related Experiment Videos
Genetic alterations in head and neck cancer
1Eastern Virginia Medical School, Norfolk.
Otolaryngologic Clinics of North America
|October 1, 1992
Summary
Ras gene mutations are rare in head and neck squamous cell carcinoma (SCCHN). However, p53 mutations are common, and chromosome 11q13 amplification may involve key oncogenes, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Genetics
- Cancer Research
Background:
- Squamous cell carcinoma of the head and neck (SCCHN) is a complex disease with various genetic alterations.
- The ras gene family is infrequently mutated in SCCHN.
- A specific DNA amplification region on chromosome 11q13 is frequently observed in SCCHN.
Purpose of the Study:
- To investigate the genetic landscape of SCCHN, focusing on gene mutations and amplifications.
- To identify critical genes within the 11q13 amplicon that drive tumor progression.
- To explore the potential of targeting dysregulated oncogenes and tumor suppressor genes for SCCHN therapy.
Main Methods:
- Genetic analysis of SCCHN samples.
- Identification of DNA amplification regions using molecular techniques.
- Localization of proto-oncogenes within amplified chromosomal regions.
Main Results:
- Ras gene family mutations are uncommon in SCCHN.
- A common amplification region at 11q13 contains a cluster of proto-oncogenes (int-2, hst-1, bcl-1, prad-1).
- Mutations in the p53 tumor suppressor gene represent the most frequent genetic alteration in SCCHN.
Conclusions:
- The 11q13 amplicon and p53 mutations are significant genetic events in SCCHN.
- Further research is required to pinpoint the specific genes responsible for the 11q13 amplicon's oncogenic activity.
- Targeting aberrant oncogenes and tumor suppressor genes presents a promising avenue for novel SCCHN therapeutic strategies.